Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Failure to comply with the 10% max Swartz holding is Swartz`s problem not PTSC...

RE: Failure to comply with the 10% max Swartz holding is Swartz`s problem not PTSC...

posted on Jun 13, 2006 04:38AM
That is true guys, however the result is still the same, if PTSC buys from someplace else...say the market, the S & L will have to sell. Same result, but if PTSC were to go direct they may be able avoid MM`s and commissions. Large number of shares would be easier to get. That`s all.

I know there is not obligation, just business.

Share
New Message
Please login to post a reply